Aggresomes and Russell bodies
Open Access
- 1 September 2000
- journal article
- review article
- Published by Springer Nature in EMBO Reports
- Vol. 1 (3), 225-231
- https://doi.org/10.1093/embo-reports/kvd052
Abstract
All cells are equipped with a proteolytic apparatus that eliminates damaged, misfolded and incorrectly assembled proteins. The principal engine of cytoplasmic proteolysis, the 26S proteasome, requires that substrates be unfolded to gain access to the active site; consequently, it is relatively ineffective at degrading aggregated proteins. Cellular indigestion occurs when the production of aggregation‐prone proteins exceeds the cell's (or organelle's) capacity to eliminate them. Cellular pathways that resolve this indigestion exist, but appear to have limited capacities. Russell bodies and aggresomes are manifestations of cellular indigestion in the endoplasmic reticulum and cytoplasmic compartments, respectively, and are often associated with disease.Keywords
This publication has 58 references indexed in Scilit:
- Regulation of Protein Secretion Through Controlled Aggregation in the Endoplasmic ReticulumScience, 2000
- Posttranslational Quality Control: Folding, Refolding, and Degrading ProteinsScience, 1999
- Setting the Standards: Quality Control in the Secretory PathwayScience, 1999
- The Role of Multiubiquitination in Dislocation and Degradation of the α Subunit of the T Cell Antigen ReceptorJournal of Biological Chemistry, 1999
- Aggregates in neurodegenerative disease: crowds and power?Trends in Neurosciences, 1999
- Role of Cue1p in Ubiquitination and Degradation at the ER SurfaceScience, 1997
- Mutation in the α-Synuclein Gene Identified in Families with Parkinson's DiseaseScience, 1997
- A protein translocation defect linked to ubiquitin conjugation at the endoplasmic reticulumNature, 1993
- Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosisNature, 1993
- Accumulation of PiZ alpha 1-antitrypsin causes liver damage in transgenic mice.Journal of Clinical Investigation, 1989